Silo Wellness (XCNQ:SILO) Change In Inventory : C$0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Silo Wellness Change In Inventory?

Silo Wellness's change in inventory for the quarter that ended in Jul. 2023 was C$0.00 Mil. It means Silo Wellness's inventory stayed the same from Apr. 2023 to Jul. 2023 .

Silo Wellness's change in inventory for the fiscal year that ended in Oct. 2022 was C$0.12 Mil. It means Silo Wellness's inventory declined by C$0.12 Mil from Oct. 2021 to Oct. 2022 .

Silo Wellness's Total Inventories for the quarter that ended in Jul. 2023 was C$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Silo Wellness's Days Inventory for the quarter that ended in Jul. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Silo Wellness's Inventory-to-Revenue for the quarter that ended in Jul. 2023 was 0.00.

Silo Wellness Change In Inventory Historical Data

The historical data trend for Silo Wellness's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silo Wellness Change In Inventory Chart

Silo Wellness Annual Data

Trend

Oct20

Oct21

Oct22

Change In Inventory

-0.10

0.12

Silo Wellness Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Change In Inventory	Get a 7-Day Free Trial										-	-	-	-	-

Silo Wellness Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Silo Wellness (XCNQ:SILO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Silo Wellness's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.117	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Silo Wellness's Inventory Turnover for the quarter that ended in Jul. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.117	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Silo Wellness's Inventory to Revenue for the quarter that ended in Jul. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.095
	=	0.00

Silo Wellness Change In Inventory Related Terms

Thank you for viewing the detailed overview of Silo Wellness's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Silo Wellness (XCNQ:SILO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silo Wellness Inc (XCNQ:SILO) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Consumers Road, Suite 702, Toronto, ON, CAN, M2J 4R4

Website

https://www.silowellness.com

Silo Wellness Inc operates psychedelic clinics and develops legal functional mushroom consumer products. It is focused on health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.

Executives

Michael Hartman

Director